TY  - JOUR 
AU  - White, H. D.
AU  - Steg, P. G.
AU  - Szarek, M.
AU  - Bhatt, D. L.
AU  - Bittner, V. A.
AU  - Diaz, R.
AU  - Edelberg, J. M.
AU  - Erglis, A.
AU  - Goodman, S. G.
AU  - Hanotin, C.
AU  - Harrington, R. A.
AU  - Jukema, J. W.
AU  - Lopes, R. D.
AU  - Mahaffey, K. W.
AU  - Moryusef, A.
AU  - Pordy, R.
AU  - Roe, M. T.
AU  - Sritara, P.
AU  - Tricoci, P.
AU  - Zeiher, A. M.
AU  - Schwartz, G. G
AU  - Iñiguez Romo, Andres
AU  - González Juanatey, José Ramón
AU  - González Juanatey, Carlos
PY  - 2019
SN  - 0195-668X
UR  - http://hdl.handle.net/20.500.11940/15753
AB  - AIMS: The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4,...
LA  - eng
KW  - Middle Aged
KW  - Humans
KW  - Antibodies
KW  - Cholesterol
KW  - Prospective Studies
KW  - Aged
KW  - Mortality
KW  - Double-Blind Method
KW  - Myocardial Infarction
TI  - Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
DO  - 10.1093/eurheartj/ehz299
T2  - European Heart Journal
M2  - 2801
KW  - CHUS
KW  - CHUVI
KW  - HULA
VL  - 40
ER  -